Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review
Crossref DOI link: https://doi.org/10.1186/1472-6939-15-83
Published Online: 2014-12-10
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Lent, Marlies
Rongen, Gerard A
Out, Henk J
License valid from 2014-12-01
Article History
Received: 19 August 2014
Accepted: 26 November 2014
First Online: 10 December 2014